Log in to save to my catalogue

Prevalence and determinants of SARS-CoV-2 neutralizing antibodies in Lebanon

Prevalence and determinants of SARS-CoV-2 neutralizing antibodies in Lebanon

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9123924

Prevalence and determinants of SARS-CoV-2 neutralizing antibodies in Lebanon

About this item

Full title

Prevalence and determinants of SARS-CoV-2 neutralizing antibodies in Lebanon

Publisher

Vienna: Springer Vienna

Journal title

Archives of virology, 2022-07, Vol.167 (7), p.1509-1519

Language

English

Formats

Publication information

Publisher

Vienna: Springer Vienna

More information

Scope and Contents

Contents

According to the Lebanese Ministry of Public Health, more than 1,053,000 cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been confirmed in Lebanon so far. The actual number of cases is likely to be higher. We conducted a serological study from October 2020 to April 2021 to estimate the prevalence of SARS-CoV-2 n...

Alternative Titles

Full title

Prevalence and determinants of SARS-CoV-2 neutralizing antibodies in Lebanon

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9123924

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9123924

Other Identifiers

ISSN

0304-8608,1432-8798

E-ISSN

1432-8798

DOI

10.1007/s00705-022-05470-2

How to access this item